291 related articles for article (PubMed ID: 22592504)
1. St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT.
Sarris J; Fava M; Schweitzer I; Mischoulon D
Pharmacopsychiatry; 2012 Nov; 45(7):275-8. PubMed ID: 22592504
[TBL] [Abstract][Full Text] [Related]
2. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
; Davidson JR; Gadde KM; Fairbank JA; Krishnan KRR; Califf RM; Binanay C; Parker CB; Pugh N; Hartwell TD; Vitiello B; Ritz L; Severe J; Cole JO; de Battista C; Doraiswamy PM; Feighner JP; Keck P; Kelsey J; Lin KM; Londborg PD; Nemeroff CB; Schatzberg AF; Sheehan DV; Srivastava RK; Taylor L; Trivedi MH; Weisler RH
JAMA; 2002 Apr; 287(14):1807-14. PubMed ID: 11939866
[TBL] [Abstract][Full Text] [Related]
3. St John's wort or sertraline? Randomized controlled trial in primary care.
van Gurp G; Meterissian GB; Haiek LN; McCusker J; Bellavance F
Can Fam Physician; 2002 May; 48():905-12. PubMed ID: 12053635
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of St John's wort in major depression: a randomized controlled trial.
Shelton RC; Keller MB; Gelenberg A; Dunner DL; Hirschfeld R; Thase ME; Russell J; Lydiard RB; Crits-Cristoph P; Gallop R; Todd L; Hellerstein D; Goodnick P; Keitner G; Stahl SM; Halbreich U
JAMA; 2001 Apr; 285(15):1978-86. PubMed ID: 11308434
[TBL] [Abstract][Full Text] [Related]
5. St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.
Sarris J; Kavanagh DJ; Deed G; Bone KM
Hum Psychopharmacol; 2009 Jan; 24(1):41-8. PubMed ID: 19090505
[TBL] [Abstract][Full Text] [Related]
6. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
[TBL] [Abstract][Full Text] [Related]
7. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study.
Brenner R; Azbel V; Madhusoodanan S; Pawlowska M
Clin Ther; 2000 Apr; 22(4):411-9. PubMed ID: 10823363
[TBL] [Abstract][Full Text] [Related]
8. St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial.
Mannel M; Kuhn U; Schmidt U; Ploch M; Murck H
J Psychiatr Res; 2010 Sep; 44(12):760-7. PubMed ID: 20181361
[TBL] [Abstract][Full Text] [Related]
9. The impact of missing data on clinical trials: a re-analysis of a placebo controlled trial of Hypericum perforatum (St Johns wort) and sertraline in major depressive disorder.
Grobler AC; Matthews G; Molenberghs G
Psychopharmacology (Berl); 2014 May; 231(9):1987-99. PubMed ID: 24232445
[TBL] [Abstract][Full Text] [Related]
10. Treatment of somatoform disorders with St. John's wort: a randomized, double-blind and placebo-controlled trial.
Müller T; Mannel M; Murck H; Rahlfs VW
Psychosom Med; 2004; 66(4):538-47. PubMed ID: 15272100
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression.
Brattström A
Phytomedicine; 2009 Apr; 16(4):277-83. PubMed ID: 19299116
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.
Gelenberg AJ; Shelton RC; Crits-Christoph P; Keller MB; Dunner DL; Hirschfeld RM; Thase ME; Russell JM; Lydiard RB; Gallop RJ; Todd L; Hellerstein DJ; Goodnick PJ; Keitner GI; Stahl SM; Halbreich U; Hopkins HS
J Clin Psychiatry; 2004 Aug; 65(8):1114-9. PubMed ID: 15323598
[TBL] [Abstract][Full Text] [Related]
13. A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
Fava M; Alpert J; Nierenberg AA; Mischoulon D; Otto MW; Zajecka J; Murck H; Rosenbaum JF
J Clin Psychopharmacol; 2005 Oct; 25(5):441-7. PubMed ID: 16160619
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study.
Randløv C; Mehlsen J; Thomsen CF; Hedman C; von Fircks H; Winther K
Phytomedicine; 2006 Mar; 13(4):215-21. PubMed ID: 16423519
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
Kalb R; Trautmann-Sponsel RD; Kieser M
Pharmacopsychiatry; 2001 May; 34(3):96-103. PubMed ID: 11434406
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
Saito YA; Rey E; Almazar-Elder AE; Harmsen WS; Zinsmeister AR; Locke GR; Talley NJ
Am J Gastroenterol; 2010 Jan; 105(1):170-7. PubMed ID: 19809408
[TBL] [Abstract][Full Text] [Related]
17. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.
Al-Akoum M; Maunsell E; Verreault R; Provencher L; Otis H; Dodin S
Menopause; 2009; 16(2):307-14. PubMed ID: 19194342
[TBL] [Abstract][Full Text] [Related]
18. St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.
Volz HP; Murck H; Kasper S; Möller HJ
Psychopharmacology (Berl); 2002 Nov; 164(3):294-300. PubMed ID: 12424553
[TBL] [Abstract][Full Text] [Related]
19. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
Lecrubier Y; Clerc G; Didi R; Kieser M
Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]